GlucoTrack (NASDAQ:GCTK) Stock Price Down 5.6% – Here’s Why

GlucoTrack, Inc. (NASDAQ:GCTK) shares dropped 5.6% on Monday. The company traded as low as $0.6820 and last traded at $0.6847. 83,091 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 4,339,918 shares. The stock had previously closed at $0.7250.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on GCTK. Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a research note on Thursday, October 15th. Wall Street Zen raised shares of GlucoTrack from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock has a consensus rating of “Sell”.

GlucoTrack Price Performance

The stock has a market capitalization of $454,400.00, a PE ratio of -0.00 and a beta of 0.73. The business’s fifty day moving average price is $2.81 and its 200-day moving average price is $6.34.

GlucoTrack Company Profile

GlucoTrack, Inc is a medical device company focused on developing glucose-monitoring technologies for people with diabetes. The company’s primary product candidate is an implantable continuous blood glucose monitoring system designed to measure glucose levels over an extended period and provide data that can support diabetes management.

GlucoTrack previously developed the GlucoTrack non-invasive glucose monitor, which was designed to estimate blood glucose levels without requiring a finger-stick blood sample.